RUNX1 and myelodysplastic syndrome: The germline mutation of RUNX1 is associated with familial platelet disorders with predispositions to myeloid malignancy (FPDMM), which is an autosomal-dominant disease characterized by thrombocytopenia and platelet dysfunction that leads to an increased risk of hematological malignancy, such as myelodysplastic syndrome [70].